News
1 minute read

MBHB Partner Kevin Noonan Quoted in BioPharma-Reporter Article Entitled, “UK High Court rules against AbbVie in Humira indication patent battle”

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a March 7, 2017 edition of BioPharma-Reporter in an article entitled, “UK High Court rules against AbbVie in Humira indication patent battle.” Biosimilar developers have welcomed a court ruling against AbbVie regarding Humira indication patents, but an IP lawyer warns the judgement is not binding outside the UK. View the article